Cite
HARVARD Citation
Uludag, G. et al. (2022). Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?. Expert opinion on biological therapy. pp. 1275-1291. [Online].